nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinine—ABCB1—ovarian cancer	0.205	1	CbGaD
Quinine—SLCO1A2—Chlorambucil—ovarian cancer	0.168	0.317	CbGbCtD
Quinine—CYP3A7—Paclitaxel—ovarian cancer	0.032	0.0603	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.032	0.0603	CbGbCtD
Quinine—ABCB1—Topotecan—ovarian cancer	0.0315	0.0595	CbGbCtD
Quinine—CYP3A5—Paclitaxel—ovarian cancer	0.024	0.0452	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0231	0.0436	CbGbCtD
Quinine—CYP3A7—Docetaxel—ovarian cancer	0.0231	0.0436	CbGbCtD
Quinine—CYP2C8—Paclitaxel—ovarian cancer	0.023	0.0435	CbGbCtD
Quinine—ABCB1—Vinorelbine—ovarian cancer	0.0222	0.0419	CbGbCtD
Quinine—CYP2D6—Vinorelbine—ovarian cancer	0.0209	0.0395	CbGbCtD
Quinine—CYP3A4—Topotecan—ovarian cancer	0.0189	0.0356	CbGbCtD
Quinine—CYP3A5—Docetaxel—ovarian cancer	0.0173	0.0327	CbGbCtD
Quinine—CYP2C9—Paclitaxel—ovarian cancer	0.0161	0.0303	CbGbCtD
Quinine—ABCB1—Paclitaxel—ovarian cancer	0.0156	0.0294	CbGbCtD
Quinine—CYP3A4—Vinorelbine—ovarian cancer	0.0133	0.0251	CbGbCtD
Quinine—ABCB1—Docetaxel—ovarian cancer	0.0113	0.0213	CbGbCtD
Quinine—CYP3A4—Paclitaxel—ovarian cancer	0.00935	0.0176	CbGbCtD
Quinine—ABCB1—Doxorubicin—ovarian cancer	0.00841	0.0159	CbGbCtD
Quinine—CYP2D6—Doxorubicin—ovarian cancer	0.00792	0.0149	CbGbCtD
Quinine—CYP3A4—Docetaxel—ovarian cancer	0.00676	0.0128	CbGbCtD
Quinine—CYP3A4—Doxorubicin—ovarian cancer	0.00504	0.00951	CbGbCtD
Quinine—GP9—testis—ovarian cancer	0.00408	0.0823	CbGeAlD
Quinine—KCNN4—myometrium—ovarian cancer	0.00237	0.0477	CbGeAlD
Quinine—KCNN4—epithelium—ovarian cancer	0.00186	0.0375	CbGeAlD
Quinine—KCNN4—decidua—ovarian cancer	0.00176	0.0354	CbGeAlD
Quinine—KCNN4—endometrium—ovarian cancer	0.00167	0.0336	CbGeAlD
Quinine—KCNN4—uterus—ovarian cancer	0.00154	0.0309	CbGeAlD
Quinine—KCNN4—female reproductive system—ovarian cancer	0.00138	0.0278	CbGeAlD
Quinine—SLC22A4—myometrium—ovarian cancer	0.00133	0.0267	CbGeAlD
Quinine—KCNN4—bone marrow—ovarian cancer	0.0013	0.0263	CbGeAlD
Quinine—KCNN4—vagina—ovarian cancer	0.00125	0.0252	CbGeAlD
Quinine—KCNN4—testis—ovarian cancer	0.00111	0.0225	CbGeAlD
Quinine—SLC22A4—decidua—ovarian cancer	0.000983	0.0198	CbGeAlD
Quinine—SLC22A4—endometrium—ovarian cancer	0.000933	0.0188	CbGeAlD
Quinine—KCNH2—myometrium—ovarian cancer	0.000928	0.0187	CbGeAlD
Quinine—SLC22A5—myometrium—ovarian cancer	0.000877	0.0177	CbGeAlD
Quinine—KCNN4—lymph node—ovarian cancer	0.000808	0.0163	CbGeAlD
Quinine—SLC22A4—female reproductive system—ovarian cancer	0.000773	0.0156	CbGeAlD
Quinine—SLC22A4—bone marrow—ovarian cancer	0.00073	0.0147	CbGeAlD
Quinine—KCNH2—uterine cervix—ovarian cancer	0.000722	0.0146	CbGeAlD
Quinine—SLC22A4—vagina—ovarian cancer	0.000699	0.0141	CbGeAlD
Quinine—SLC22A5—uterine cervix—ovarian cancer	0.000683	0.0138	CbGeAlD
Quinine—SLC22A1—vagina—ovarian cancer	0.000666	0.0134	CbGeAlD
Quinine—KCNH2—endometrium—ovarian cancer	0.000653	0.0132	CbGeAlD
Quinine—SLC22A5—endometrium—ovarian cancer	0.000617	0.0124	CbGeAlD
Quinine—CYP1A1—epithelium—ovarian cancer	0.000615	0.0124	CbGeAlD
Quinine—CYP1A1—uterine cervix—ovarian cancer	0.00061	0.0123	CbGeAlD
Quinine—KCNH2—uterus—ovarian cancer	0.000602	0.0121	CbGeAlD
Quinine—CYP2C8—endometrium—ovarian cancer	0.000598	0.012	CbGeAlD
Quinine—CYP3A5—uterine cervix—ovarian cancer	0.000596	0.012	CbGeAlD
Quinine—SLCO1A2—testis—ovarian cancer	0.000572	0.0115	CbGeAlD
Quinine—KCNH2—female reproductive system—ovarian cancer	0.000541	0.0109	CbGeAlD
Quinine—CYP2C19—vagina—ovarian cancer	0.000513	0.0103	CbGeAlD
Quinine—SLC22A5—female reproductive system—ovarian cancer	0.000511	0.0103	CbGeAlD
Quinine—KCNH2—bone marrow—ovarian cancer	0.000511	0.0103	CbGeAlD
Quinine—CYP1A1—uterus—ovarian cancer	0.000508	0.0102	CbGeAlD
Quinine—CYP2C8—female reproductive system—ovarian cancer	0.000495	0.00998	CbGeAlD
Quinine—KCNH2—female gonad—ovarian cancer	0.000492	0.00992	CbGeAlD
Quinine—KCNH2—vagina—ovarian cancer	0.000489	0.00986	CbGeAlD
Quinine—SLC22A5—female gonad—ovarian cancer	0.000465	0.00938	CbGeAlD
Quinine—SLC22A5—vagina—ovarian cancer	0.000463	0.00932	CbGeAlD
Quinine—CYP1A1—female reproductive system—ovarian cancer	0.000457	0.00921	CbGeAlD
Quinine—SLC22A4—lymph node—ovarian cancer	0.000452	0.00911	CbGeAlD
Quinine—CYP2C8—vagina—ovarian cancer	0.000448	0.00902	CbGeAlD
Quinine—CYP2C9—female reproductive system—ovarian cancer	0.00044	0.00886	CbGeAlD
Quinine—KCNH2—testis—ovarian cancer	0.000437	0.0088	CbGeAlD
Quinine—CYP2E1—female reproductive system—ovarian cancer	0.000417	0.0084	CbGeAlD
Quinine—CYP1A1—female gonad—ovarian cancer	0.000416	0.00838	CbGeAlD
Quinine—CYP1A1—vagina—ovarian cancer	0.000413	0.00833	CbGeAlD
Quinine—SLC22A5—testis—ovarian cancer	0.000413	0.00832	CbGeAlD
Quinine—ABCB1—myometrium—ovarian cancer	0.000407	0.0082	CbGeAlD
Quinine—CYP3A5—female gonad—ovarian cancer	0.000407	0.00819	CbGeAlD
Quinine—CYP3A5—vagina—ovarian cancer	0.000404	0.00814	CbGeAlD
Quinine—CYP2C8—testis—ovarian cancer	0.0004	0.00805	CbGeAlD
Quinine—ABCB1—embryo—ovarian cancer	0.000392	0.00789	CbGeAlD
Quinine—CYP2E1—testis—ovarian cancer	0.000336	0.00678	CbGeAlD
Quinine—CYP3A4—female reproductive system—ovarian cancer	0.000335	0.00676	CbGeAlD
Quinine—CYP2D6—female reproductive system—ovarian cancer	0.00033	0.00665	CbGeAlD
Quinine—ABCB1—epithelium—ovarian cancer	0.00032	0.00644	CbGeAlD
Quinine—ABCB1—uterine cervix—ovarian cancer	0.000317	0.00638	CbGeAlD
Quinine—KCNH2—lymph node—ovarian cancer	0.000317	0.00638	CbGeAlD
Quinine—ABCB1—decidua—ovarian cancer	0.000302	0.00608	CbGeAlD
Quinine—CYP2D6—female gonad—ovarian cancer	0.0003	0.00605	CbGeAlD
Quinine—SLC22A5—lymph node—ovarian cancer	0.000299	0.00603	CbGeAlD
Quinine—ABCB1—endometrium—ovarian cancer	0.000287	0.00577	CbGeAlD
Quinine—CYP1A1—lymph node—ovarian cancer	0.000267	0.00539	CbGeAlD
Quinine—CYP2D6—testis—ovarian cancer	0.000266	0.00537	CbGeAlD
Quinine—ABCB1—gonad—ovarian cancer	0.000266	0.00536	CbGeAlD
Quinine—ABCB1—uterus—ovarian cancer	0.000264	0.00532	CbGeAlD
Quinine—ABCB1—female reproductive system—ovarian cancer	0.000237	0.00478	CbGeAlD
Quinine—ABCB1—bone marrow—ovarian cancer	0.000224	0.00452	CbGeAlD
Quinine—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000219	0.00119	CcSEcCtD
Quinine—Vertigo—Paclitaxel—ovarian cancer	0.000219	0.00119	CcSEcCtD
Quinine—Syncope—Paclitaxel—ovarian cancer	0.000218	0.00119	CcSEcCtD
Quinine—Leukopenia—Paclitaxel—ovarian cancer	0.000218	0.00119	CcSEcCtD
Quinine—Rash—Topotecan—ovarian cancer	0.000218	0.00119	CcSEcCtD
Quinine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000218	0.00119	CcSEcCtD
Quinine—Dermatitis—Topotecan—ovarian cancer	0.000218	0.00118	CcSEcCtD
Quinine—Ataxia—Epirubicin—ovarian cancer	0.000217	0.00118	CcSEcCtD
Quinine—Headache—Topotecan—ovarian cancer	0.000216	0.00118	CcSEcCtD
Quinine—ABCB1—female gonad—ovarian cancer	0.000216	0.00435	CbGeAlD
Quinine—Palpitations—Paclitaxel—ovarian cancer	0.000215	0.00117	CcSEcCtD
Quinine—Vomiting—Melphalan—ovarian cancer	0.000215	0.00117	CcSEcCtD
Quinine—ABCB1—vagina—ovarian cancer	0.000215	0.00433	CbGeAlD
Quinine—Immune system disorder—Docetaxel—ovarian cancer	0.000214	0.00117	CcSEcCtD
Quinine—Loss of consciousness—Paclitaxel—ovarian cancer	0.000214	0.00117	CcSEcCtD
Quinine—Diplopia—Doxorubicin—ovarian cancer	0.000214	0.00116	CcSEcCtD
Quinine—Mediastinal disorder—Docetaxel—ovarian cancer	0.000214	0.00116	CcSEcCtD
Quinine—Liver function test abnormal—Epirubicin—ovarian cancer	0.000214	0.00116	CcSEcCtD
Quinine—Rash—Melphalan—ovarian cancer	0.000213	0.00116	CcSEcCtD
Quinine—Dermatitis—Melphalan—ovarian cancer	0.000213	0.00116	CcSEcCtD
Quinine—Chills—Docetaxel—ovarian cancer	0.000213	0.00116	CcSEcCtD
Quinine—Asthenia—Vinorelbine—ovarian cancer	0.000212	0.00115	CcSEcCtD
Quinine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000211	0.00115	CcSEcCtD
Quinine—Abdominal pain upper—Epirubicin—ovarian cancer	0.000211	0.00115	CcSEcCtD
Quinine—Convulsion—Paclitaxel—ovarian cancer	0.000211	0.00115	CcSEcCtD
Quinine—Pruritus—Vinorelbine—ovarian cancer	0.000209	0.00114	CcSEcCtD
Quinine—Breast disorder—Epirubicin—ovarian cancer	0.000209	0.00114	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000208	0.00113	CcSEcCtD
Quinine—Mental disorder—Docetaxel—ovarian cancer	0.000208	0.00113	CcSEcCtD
Quinine—Myalgia—Paclitaxel—ovarian cancer	0.000207	0.00113	CcSEcCtD
Quinine—Chest pain—Paclitaxel—ovarian cancer	0.000207	0.00113	CcSEcCtD
Quinine—Malnutrition—Docetaxel—ovarian cancer	0.000207	0.00112	CcSEcCtD
Quinine—Erythema—Docetaxel—ovarian cancer	0.000207	0.00112	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000206	0.00112	CcSEcCtD
Quinine—Nausea—Topotecan—ovarian cancer	0.000205	0.00112	CcSEcCtD
Quinine—Muscular weakness—Epirubicin—ovarian cancer	0.000204	0.00111	CcSEcCtD
Quinine—Cardiac arrest—Doxorubicin—ovarian cancer	0.000204	0.00111	CcSEcCtD
Quinine—Diarrhoea—Vinorelbine—ovarian cancer	0.000202	0.0011	CcSEcCtD
Quinine—Ataxia—Doxorubicin—ovarian cancer	0.000201	0.0011	CcSEcCtD
Quinine—Nausea—Melphalan—ovarian cancer	0.000201	0.00109	CcSEcCtD
Quinine—Confusional state—Paclitaxel—ovarian cancer	0.0002	0.00109	CcSEcCtD
Quinine—Asthma—Epirubicin—ovarian cancer	0.0002	0.00109	CcSEcCtD
Quinine—Oedema—Paclitaxel—ovarian cancer	0.000199	0.00108	CcSEcCtD
Quinine—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000198	0.00108	CcSEcCtD
Quinine—Shock—Paclitaxel—ovarian cancer	0.000196	0.00106	CcSEcCtD
Quinine—Dizziness—Vinorelbine—ovarian cancer	0.000195	0.00106	CcSEcCtD
Quinine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000195	0.00106	CcSEcCtD
Quinine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000195	0.00106	CcSEcCtD
Quinine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000195	0.00106	CcSEcCtD
Quinine—Angina pectoris—Epirubicin—ovarian cancer	0.000195	0.00106	CcSEcCtD
Quinine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000195	0.00106	CcSEcCtD
Quinine—Tachycardia—Paclitaxel—ovarian cancer	0.000194	0.00106	CcSEcCtD
Quinine—Breast disorder—Doxorubicin—ovarian cancer	0.000193	0.00105	CcSEcCtD
Quinine—Skin disorder—Paclitaxel—ovarian cancer	0.000193	0.00105	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000193	0.00105	CcSEcCtD
Quinine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000192	0.00105	CcSEcCtD
Quinine—ABCB1—testis—ovarian cancer	0.000192	0.00386	CbGeAlD
Quinine—Pancytopenia—Epirubicin—ovarian cancer	0.00019	0.00103	CcSEcCtD
Quinine—Anorexia—Paclitaxel—ovarian cancer	0.00019	0.00103	CcSEcCtD
Quinine—Muscular weakness—Doxorubicin—ovarian cancer	0.000189	0.00103	CcSEcCtD
Quinine—Vomiting—Vinorelbine—ovarian cancer	0.000188	0.00102	CcSEcCtD
Quinine—Neutropenia—Epirubicin—ovarian cancer	0.000187	0.00102	CcSEcCtD
Quinine—Rash—Vinorelbine—ovarian cancer	0.000186	0.00101	CcSEcCtD
Quinine—Dermatitis—Vinorelbine—ovarian cancer	0.000186	0.00101	CcSEcCtD
Quinine—Hypotension—Paclitaxel—ovarian cancer	0.000186	0.00101	CcSEcCtD
Quinine—Headache—Vinorelbine—ovarian cancer	0.000185	0.00101	CcSEcCtD
Quinine—Syncope—Docetaxel—ovarian cancer	0.000185	0.00101	CcSEcCtD
Quinine—Asthma—Doxorubicin—ovarian cancer	0.000185	0.00101	CcSEcCtD
Quinine—Leukopenia—Docetaxel—ovarian cancer	0.000185	0.00101	CcSEcCtD
Quinine—Palpitations—Docetaxel—ovarian cancer	0.000182	0.000993	CcSEcCtD
Quinine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000182	0.000993	CcSEcCtD
Quinine—Loss of consciousness—Docetaxel—ovarian cancer	0.000182	0.000988	CcSEcCtD
Quinine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000181	0.000986	CcSEcCtD
Quinine—Angina pectoris—Doxorubicin—ovarian cancer	0.00018	0.00098	CcSEcCtD
Quinine—Convulsion—Docetaxel—ovarian cancer	0.000179	0.000974	CcSEcCtD
Quinine—Dyspnoea—Paclitaxel—ovarian cancer	0.000177	0.000965	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000177	0.000962	CcSEcCtD
Quinine—Chest pain—Docetaxel—ovarian cancer	0.000176	0.000957	CcSEcCtD
Quinine—Myalgia—Docetaxel—ovarian cancer	0.000176	0.000957	CcSEcCtD
Quinine—Pancytopenia—Doxorubicin—ovarian cancer	0.000176	0.000956	CcSEcCtD
Quinine—Nausea—Vinorelbine—ovarian cancer	0.000176	0.000956	CcSEcCtD
Quinine—Renal failure—Epirubicin—ovarian cancer	0.000175	0.000953	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000175	0.00095	CcSEcCtD
Quinine—Jaundice—Epirubicin—ovarian cancer	0.000174	0.000945	CcSEcCtD
Quinine—Neutropenia—Doxorubicin—ovarian cancer	0.000173	0.000941	CcSEcCtD
Quinine—Decreased appetite—Paclitaxel—ovarian cancer	0.000173	0.000941	CcSEcCtD
Quinine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000172	0.000934	CcSEcCtD
Quinine—Sweating—Epirubicin—ovarian cancer	0.000171	0.00093	CcSEcCtD
Quinine—Confusional state—Docetaxel—ovarian cancer	0.00017	0.000925	CcSEcCtD
Quinine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000169	0.000919	CcSEcCtD
Quinine—Oedema—Docetaxel—ovarian cancer	0.000169	0.000917	CcSEcCtD
Quinine—Agranulocytosis—Epirubicin—ovarian cancer	0.000166	0.000905	CcSEcCtD
Quinine—Shock—Docetaxel—ovarian cancer	0.000166	0.000902	CcSEcCtD
Quinine—Nervous system disorder—Docetaxel—ovarian cancer	0.000165	0.000899	CcSEcCtD
Quinine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000165	0.000898	CcSEcCtD
Quinine—Tachycardia—Docetaxel—ovarian cancer	0.000164	0.000895	CcSEcCtD
Quinine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000164	0.000892	CcSEcCtD
Quinine—Skin disorder—Docetaxel—ovarian cancer	0.000164	0.000891	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000164	0.00089	CcSEcCtD
Quinine—Bradycardia—Epirubicin—ovarian cancer	0.000163	0.000886	CcSEcCtD
Quinine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000163	0.000885	CcSEcCtD
Quinine—Renal failure—Doxorubicin—ovarian cancer	0.000162	0.000882	CcSEcCtD
Quinine—Haemoglobin—Epirubicin—ovarian cancer	0.000161	0.000875	CcSEcCtD
Quinine—Jaundice—Doxorubicin—ovarian cancer	0.000161	0.000875	CcSEcCtD
Quinine—Anorexia—Docetaxel—ovarian cancer	0.000161	0.000874	CcSEcCtD
Quinine—Haemorrhage—Epirubicin—ovarian cancer	0.00016	0.000871	CcSEcCtD
Quinine—Hepatitis—Epirubicin—ovarian cancer	0.00016	0.000871	CcSEcCtD
Quinine—Sweating—Doxorubicin—ovarian cancer	0.000158	0.00086	CcSEcCtD
Quinine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000158	0.00086	CcSEcCtD
Quinine—Urticaria—Paclitaxel—ovarian cancer	0.000158	0.00086	CcSEcCtD
Quinine—Hypotension—Docetaxel—ovarian cancer	0.000157	0.000857	CcSEcCtD
Quinine—Abdominal pain—Paclitaxel—ovarian cancer	0.000157	0.000855	CcSEcCtD
Quinine—Body temperature increased—Paclitaxel—ovarian cancer	0.000157	0.000855	CcSEcCtD
Quinine—Urethral disorder—Epirubicin—ovarian cancer	0.000157	0.000853	CcSEcCtD
Quinine—Visual impairment—Epirubicin—ovarian cancer	0.000154	0.000839	CcSEcCtD
Quinine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000154	0.000837	CcSEcCtD
Quinine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000154	0.000836	CcSEcCtD
Quinine—Erythema multiforme—Epirubicin—ovarian cancer	0.000151	0.000823	CcSEcCtD
Quinine—Bradycardia—Doxorubicin—ovarian cancer	0.000151	0.00082	CcSEcCtD
Quinine—Dyspnoea—Docetaxel—ovarian cancer	0.00015	0.000818	CcSEcCtD
Quinine—Eye disorder—Epirubicin—ovarian cancer	0.00015	0.000814	CcSEcCtD
Quinine—Tinnitus—Epirubicin—ovarian cancer	0.000149	0.000812	CcSEcCtD
Quinine—Haemoglobin—Doxorubicin—ovarian cancer	0.000149	0.00081	CcSEcCtD
Quinine—Flushing—Epirubicin—ovarian cancer	0.000149	0.000808	CcSEcCtD
Quinine—Cardiac disorder—Epirubicin—ovarian cancer	0.000149	0.000808	CcSEcCtD
Quinine—Haemorrhage—Doxorubicin—ovarian cancer	0.000148	0.000806	CcSEcCtD
Quinine—Hepatitis—Doxorubicin—ovarian cancer	0.000148	0.000806	CcSEcCtD
Quinine—Decreased appetite—Docetaxel—ovarian cancer	0.000147	0.000797	CcSEcCtD
Quinine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000147	0.000797	CcSEcCtD
Quinine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000146	0.000796	CcSEcCtD
Quinine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000146	0.000792	CcSEcCtD
Quinine—Urethral disorder—Doxorubicin—ovarian cancer	0.000145	0.00079	CcSEcCtD
Quinine—Immune system disorder—Epirubicin—ovarian cancer	0.000145	0.000786	CcSEcCtD
Quinine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000144	0.000785	CcSEcCtD
Quinine—Chills—Epirubicin—ovarian cancer	0.000144	0.000781	CcSEcCtD
Quinine—Visual impairment—Doxorubicin—ovarian cancer	0.000143	0.000776	CcSEcCtD
Quinine—Asthenia—Paclitaxel—ovarian cancer	0.000143	0.000776	CcSEcCtD
Quinine—Pruritus—Paclitaxel—ovarian cancer	0.000141	0.000766	CcSEcCtD
Quinine—Mental disorder—Epirubicin—ovarian cancer	0.00014	0.000763	CcSEcCtD
Quinine—Erythema multiforme—Doxorubicin—ovarian cancer	0.00014	0.000762	CcSEcCtD
Quinine—Malnutrition—Epirubicin—ovarian cancer	0.000139	0.000758	CcSEcCtD
Quinine—Erythema—Epirubicin—ovarian cancer	0.000139	0.000758	CcSEcCtD
Quinine—Feeling abnormal—Docetaxel—ovarian cancer	0.000139	0.000756	CcSEcCtD
Quinine—ABCB1—lymph node—ovarian cancer	0.000139	0.0028	CbGeAlD
Quinine—Eye disorder—Doxorubicin—ovarian cancer	0.000138	0.000753	CcSEcCtD
Quinine—Tinnitus—Doxorubicin—ovarian cancer	0.000138	0.000751	CcSEcCtD
Quinine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000138	0.00075	CcSEcCtD
Quinine—Flushing—Doxorubicin—ovarian cancer	0.000137	0.000748	CcSEcCtD
Quinine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000137	0.000748	CcSEcCtD
Quinine—Diarrhoea—Paclitaxel—ovarian cancer	0.000136	0.00074	CcSEcCtD
Quinine—Immune system disorder—Doxorubicin—ovarian cancer	0.000134	0.000728	CcSEcCtD
Quinine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000133	0.000726	CcSEcCtD
Quinine—Body temperature increased—Docetaxel—ovarian cancer	0.000133	0.000725	CcSEcCtD
Quinine—Abdominal pain—Docetaxel—ovarian cancer	0.000133	0.000725	CcSEcCtD
Quinine—Chills—Doxorubicin—ovarian cancer	0.000133	0.000723	CcSEcCtD
Quinine—Dizziness—Paclitaxel—ovarian cancer	0.000131	0.000715	CcSEcCtD
Quinine—Vision blurred—Epirubicin—ovarian cancer	0.000131	0.000714	CcSEcCtD
Quinine—Mental disorder—Doxorubicin—ovarian cancer	0.00013	0.000706	CcSEcCtD
Quinine—Malnutrition—Doxorubicin—ovarian cancer	0.000129	0.000701	CcSEcCtD
Quinine—Erythema—Doxorubicin—ovarian cancer	0.000129	0.000701	CcSEcCtD
Quinine—Agitation—Epirubicin—ovarian cancer	0.000128	0.000697	CcSEcCtD
Quinine—Vomiting—Paclitaxel—ovarian cancer	0.000126	0.000688	CcSEcCtD
Quinine—Rash—Paclitaxel—ovarian cancer	0.000125	0.000682	CcSEcCtD
Quinine—Dermatitis—Paclitaxel—ovarian cancer	0.000125	0.000682	CcSEcCtD
Quinine—Vertigo—Epirubicin—ovarian cancer	0.000125	0.000681	CcSEcCtD
Quinine—Syncope—Epirubicin—ovarian cancer	0.000125	0.00068	CcSEcCtD
Quinine—Leukopenia—Epirubicin—ovarian cancer	0.000125	0.000678	CcSEcCtD
Quinine—Headache—Paclitaxel—ovarian cancer	0.000125	0.000678	CcSEcCtD
Quinine—Hypersensitivity—Docetaxel—ovarian cancer	0.000124	0.000676	CcSEcCtD
Quinine—Palpitations—Epirubicin—ovarian cancer	0.000123	0.00067	CcSEcCtD
Quinine—Loss of consciousness—Epirubicin—ovarian cancer	0.000122	0.000666	CcSEcCtD
Quinine—Vision blurred—Doxorubicin—ovarian cancer	0.000121	0.000661	CcSEcCtD
Quinine—Asthenia—Docetaxel—ovarian cancer	0.000121	0.000658	CcSEcCtD
Quinine—Convulsion—Epirubicin—ovarian cancer	0.000121	0.000657	CcSEcCtD
Quinine—Pruritus—Docetaxel—ovarian cancer	0.000119	0.000649	CcSEcCtD
Quinine—Chest pain—Epirubicin—ovarian cancer	0.000119	0.000645	CcSEcCtD
Quinine—Myalgia—Epirubicin—ovarian cancer	0.000119	0.000645	CcSEcCtD
Quinine—Agitation—Doxorubicin—ovarian cancer	0.000118	0.000644	CcSEcCtD
Quinine—Nausea—Paclitaxel—ovarian cancer	0.000118	0.000643	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000118	0.000641	CcSEcCtD
Quinine—Vertigo—Doxorubicin—ovarian cancer	0.000116	0.00063	CcSEcCtD
Quinine—Syncope—Doxorubicin—ovarian cancer	0.000116	0.000629	CcSEcCtD
Quinine—Leukopenia—Doxorubicin—ovarian cancer	0.000115	0.000628	CcSEcCtD
Quinine—Diarrhoea—Docetaxel—ovarian cancer	0.000115	0.000627	CcSEcCtD
Quinine—Confusional state—Epirubicin—ovarian cancer	0.000115	0.000624	CcSEcCtD
Quinine—Palpitations—Doxorubicin—ovarian cancer	0.000114	0.00062	CcSEcCtD
Quinine—Oedema—Epirubicin—ovarian cancer	0.000114	0.000619	CcSEcCtD
Quinine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000113	0.000616	CcSEcCtD
Quinine—Shock—Epirubicin—ovarian cancer	0.000112	0.000609	CcSEcCtD
Quinine—Convulsion—Doxorubicin—ovarian cancer	0.000112	0.000608	CcSEcCtD
Quinine—Nervous system disorder—Epirubicin—ovarian cancer	0.000111	0.000607	CcSEcCtD
Quinine—Dizziness—Docetaxel—ovarian cancer	0.000111	0.000606	CcSEcCtD
Quinine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000111	0.000606	CcSEcCtD
Quinine—Tachycardia—Epirubicin—ovarian cancer	0.000111	0.000604	CcSEcCtD
Quinine—Skin disorder—Epirubicin—ovarian cancer	0.00011	0.000601	CcSEcCtD
Quinine—Hyperhidrosis—Epirubicin—ovarian cancer	0.00011	0.000598	CcSEcCtD
Quinine—Chest pain—Doxorubicin—ovarian cancer	0.00011	0.000597	CcSEcCtD
Quinine—Myalgia—Doxorubicin—ovarian cancer	0.00011	0.000597	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000109	0.000593	CcSEcCtD
Quinine—Anorexia—Epirubicin—ovarian cancer	0.000108	0.00059	CcSEcCtD
Quinine—Vomiting—Docetaxel—ovarian cancer	0.000107	0.000583	CcSEcCtD
Quinine—Rash—Docetaxel—ovarian cancer	0.000106	0.000578	CcSEcCtD
Quinine—Hypotension—Epirubicin—ovarian cancer	0.000106	0.000578	CcSEcCtD
Quinine—Dermatitis—Docetaxel—ovarian cancer	0.000106	0.000578	CcSEcCtD
Quinine—Confusional state—Doxorubicin—ovarian cancer	0.000106	0.000577	CcSEcCtD
Quinine—Headache—Docetaxel—ovarian cancer	0.000106	0.000575	CcSEcCtD
Quinine—Oedema—Doxorubicin—ovarian cancer	0.000105	0.000572	CcSEcCtD
Quinine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000104	0.000564	CcSEcCtD
Quinine—Shock—Doxorubicin—ovarian cancer	0.000103	0.000563	CcSEcCtD
Quinine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000103	0.000561	CcSEcCtD
Quinine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000103	0.00056	CcSEcCtD
Quinine—Tachycardia—Doxorubicin—ovarian cancer	0.000103	0.000559	CcSEcCtD
Quinine—Skin disorder—Doxorubicin—ovarian cancer	0.000102	0.000556	CcSEcCtD
Quinine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000102	0.000553	CcSEcCtD
Quinine—Dyspnoea—Epirubicin—ovarian cancer	0.000101	0.000551	CcSEcCtD
Quinine—Anorexia—Doxorubicin—ovarian cancer	0.0001	0.000546	CcSEcCtD
Quinine—Nausea—Docetaxel—ovarian cancer	0.0001	0.000545	CcSEcCtD
Quinine—Decreased appetite—Epirubicin—ovarian cancer	9.88e-05	0.000538	CcSEcCtD
Quinine—Hypotension—Doxorubicin—ovarian cancer	9.83e-05	0.000535	CcSEcCtD
Quinine—Gastrointestinal disorder—Epirubicin—ovarian cancer	9.81e-05	0.000534	CcSEcCtD
Quinine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	9.58e-05	0.000521	CcSEcCtD
Quinine—Dyspnoea—Doxorubicin—ovarian cancer	9.38e-05	0.00051	CcSEcCtD
Quinine—Feeling abnormal—Epirubicin—ovarian cancer	9.37e-05	0.00051	CcSEcCtD
Quinine—Gastrointestinal pain—Epirubicin—ovarian cancer	9.3e-05	0.000506	CcSEcCtD
Quinine—Decreased appetite—Doxorubicin—ovarian cancer	9.14e-05	0.000498	CcSEcCtD
Quinine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	9.08e-05	0.000494	CcSEcCtD
Quinine—Urticaria—Epirubicin—ovarian cancer	9.03e-05	0.000491	CcSEcCtD
Quinine—Body temperature increased—Epirubicin—ovarian cancer	8.99e-05	0.000489	CcSEcCtD
Quinine—Abdominal pain—Epirubicin—ovarian cancer	8.99e-05	0.000489	CcSEcCtD
Quinine—Feeling abnormal—Doxorubicin—ovarian cancer	8.67e-05	0.000472	CcSEcCtD
Quinine—Gastrointestinal pain—Doxorubicin—ovarian cancer	8.6e-05	0.000468	CcSEcCtD
Quinine—Hypersensitivity—Epirubicin—ovarian cancer	8.38e-05	0.000456	CcSEcCtD
Quinine—Urticaria—Doxorubicin—ovarian cancer	8.36e-05	0.000455	CcSEcCtD
Quinine—Abdominal pain—Doxorubicin—ovarian cancer	8.32e-05	0.000452	CcSEcCtD
Quinine—Body temperature increased—Doxorubicin—ovarian cancer	8.32e-05	0.000452	CcSEcCtD
Quinine—Asthenia—Epirubicin—ovarian cancer	8.16e-05	0.000444	CcSEcCtD
Quinine—Pruritus—Epirubicin—ovarian cancer	8.04e-05	0.000438	CcSEcCtD
Quinine—Diarrhoea—Epirubicin—ovarian cancer	7.78e-05	0.000423	CcSEcCtD
Quinine—Hypersensitivity—Doxorubicin—ovarian cancer	7.75e-05	0.000422	CcSEcCtD
Quinine—Asthenia—Doxorubicin—ovarian cancer	7.55e-05	0.000411	CcSEcCtD
Quinine—Dizziness—Epirubicin—ovarian cancer	7.52e-05	0.000409	CcSEcCtD
Quinine—Pruritus—Doxorubicin—ovarian cancer	7.44e-05	0.000405	CcSEcCtD
Quinine—Vomiting—Epirubicin—ovarian cancer	7.23e-05	0.000393	CcSEcCtD
Quinine—Diarrhoea—Doxorubicin—ovarian cancer	7.2e-05	0.000392	CcSEcCtD
Quinine—Rash—Epirubicin—ovarian cancer	7.17e-05	0.00039	CcSEcCtD
Quinine—Dermatitis—Epirubicin—ovarian cancer	7.16e-05	0.00039	CcSEcCtD
Quinine—Headache—Epirubicin—ovarian cancer	7.12e-05	0.000388	CcSEcCtD
Quinine—Dizziness—Doxorubicin—ovarian cancer	6.96e-05	0.000378	CcSEcCtD
Quinine—Nausea—Epirubicin—ovarian cancer	6.75e-05	0.000367	CcSEcCtD
Quinine—Vomiting—Doxorubicin—ovarian cancer	6.69e-05	0.000364	CcSEcCtD
Quinine—Rash—Doxorubicin—ovarian cancer	6.63e-05	0.000361	CcSEcCtD
Quinine—Dermatitis—Doxorubicin—ovarian cancer	6.63e-05	0.000361	CcSEcCtD
Quinine—Headache—Doxorubicin—ovarian cancer	6.59e-05	0.000359	CcSEcCtD
Quinine—Nausea—Doxorubicin—ovarian cancer	6.25e-05	0.00034	CcSEcCtD
Quinine—SLC22A1—Metabolism—ABCB1—ovarian cancer	7.97e-06	0.00025	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	7.86e-06	0.000246	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—SLC2A1—ovarian cancer	7.86e-06	0.000246	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—SLC2A1—ovarian cancer	7.84e-06	0.000246	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—YAP1—ovarian cancer	7.83e-06	0.000245	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—TYMS—ovarian cancer	7.83e-06	0.000245	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—FASN—ovarian cancer	7.8e-06	0.000244	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.75e-06	0.000243	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.75e-06	0.000243	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—IL6ST—ovarian cancer	7.74e-06	0.000242	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—SLC5A5—ovarian cancer	7.67e-06	0.00024	CbGpPWpGaD
Quinine—ABCB1—Metabolism—YAP1—ovarian cancer	7.64e-06	0.000239	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.63e-06	0.000239	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—CYP1B1—ovarian cancer	7.53e-06	0.000236	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—CYP1B1—ovarian cancer	7.52e-06	0.000235	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—PIK3CG—ovarian cancer	7.44e-06	0.000233	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—SLC2A1—ovarian cancer	7.41e-06	0.000232	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.25e-06	0.000227	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—PIK3CD—ovarian cancer	7.2e-06	0.000226	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—YAP1—ovarian cancer	7.2e-06	0.000225	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—FASN—ovarian cancer	7.15e-06	0.000224	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—YAP1—ovarian cancer	7.14e-06	0.000224	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—CYP1B1—ovarian cancer	7.1e-06	0.000222	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.06e-06	0.000221	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—SLC5A5—ovarian cancer	7.03e-06	0.00022	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.02e-06	0.00022	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.02e-06	0.00022	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	6.91e-06	0.000217	CbGpPWpGaD
Quinine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	6.91e-06	0.000216	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.81e-06	0.000213	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—SLC2A1—ovarian cancer	6.79e-06	0.000213	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—CAV1—ovarian cancer	6.78e-06	0.000212	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—CAV1—ovarian cancer	6.77e-06	0.000212	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	6.68e-06	0.000209	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	6.67e-06	0.000209	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.65e-06	0.000208	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.63e-06	0.000208	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PPP2R1A—ovarian cancer	6.56e-06	0.000206	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—PIK3CD—ovarian cancer	6.54e-06	0.000205	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—CYP1B1—ovarian cancer	6.51e-06	0.000204	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—FASN—ovarian cancer	6.38e-06	0.0002	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—CAV1—ovarian cancer	6.31e-06	0.000198	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	6.3e-06	0.000197	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—PIK3CB—ovarian cancer	6.28e-06	0.000197	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—SLC5A5—ovarian cancer	6.28e-06	0.000197	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.27e-06	0.000196	CbGpPWpGaD
Quinine—ABCB1—Metabolism—FASN—ovarian cancer	6.23e-06	0.000195	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.21e-06	0.000194	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—ABCB1—ovarian cancer	6.2e-06	0.000194	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—ABCB1—ovarian cancer	6.19e-06	0.000194	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CG—ovarian cancer	6.17e-06	0.000193	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CG—ovarian cancer	6.16e-06	0.000193	CbGpPWpGaD
Quinine—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.13e-06	0.000192	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—YAP1—ovarian cancer	6.1e-06	0.000191	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—TYMS—ovarian cancer	6.09e-06	0.000191	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—TYMS—ovarian cancer	6.08e-06	0.00019	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—SLC2A1—ovarian cancer	6.06e-06	0.00019	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.03e-06	0.000189	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—CXCL8—ovarian cancer	6.03e-06	0.000189	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	6.03e-06	0.000189	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.93e-06	0.000186	CbGpPWpGaD
Quinine—ABCB1—Metabolism—SLC2A1—ovarian cancer	5.92e-06	0.000185	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—FASN—ovarian cancer	5.87e-06	0.000184	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—ABCB1—ovarian cancer	5.85e-06	0.000183	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—FASN—ovarian cancer	5.82e-06	0.000182	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—CYP1B1—ovarian cancer	5.81e-06	0.000182	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	5.77e-06	0.000181	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	5.77e-06	0.000181	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—IL2—ovarian cancer	5.76e-06	0.000181	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.75e-06	0.00018	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CG—ovarian cancer	5.74e-06	0.00018	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—TYMS—ovarian cancer	5.74e-06	0.00018	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—SLC5A5—ovarian cancer	5.72e-06	0.000179	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—PIK3CB—ovarian cancer	5.7e-06	0.000179	CbGpPWpGaD
Quinine—ABCB1—Metabolism—CYP1B1—ovarian cancer	5.67e-06	0.000178	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	5.57e-06	0.000175	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—SLC2A1—ovarian cancer	5.53e-06	0.000173	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—CXCL8—ovarian cancer	5.48e-06	0.000172	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CD—ovarian cancer	5.43e-06	0.00017	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CD—ovarian cancer	5.42e-06	0.00017	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.41e-06	0.00017	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—ABCB1—ovarian cancer	5.36e-06	0.000168	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	5.34e-06	0.000167	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.31e-06	0.000166	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CYP1B1—ovarian cancer	5.3e-06	0.000166	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—TYMS—ovarian cancer	5.27e-06	0.000165	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—IL2—ovarian cancer	5.23e-06	0.000164	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TERT—ovarian cancer	5.21e-06	0.000163	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PTEN—ovarian cancer	5.21e-06	0.000163	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	5.15e-06	0.000161	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.13e-06	0.000161	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CD—ovarian cancer	5.05e-06	0.000158	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.03e-06	0.000158	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—FASN—ovarian cancer	4.97e-06	0.000156	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—CAV1—ovarian cancer	4.91e-06	0.000154	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—CAV1—ovarian cancer	4.9e-06	0.000153	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—SLC5A5—ovarian cancer	4.89e-06	0.000153	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CAV1—ovarian cancer	4.82e-06	0.000151	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—ABCB1—ovarian cancer	4.79e-06	0.00015	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	4.74e-06	0.000148	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CB—ovarian cancer	4.73e-06	0.000148	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—SLC2A1—ovarian cancer	4.72e-06	0.000148	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CB—ovarian cancer	4.72e-06	0.000148	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—YAP1—ovarian cancer	4.71e-06	0.000147	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—TYMS—ovarian cancer	4.7e-06	0.000147	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	4.7e-06	0.000147	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.68e-06	0.000146	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—ESR1—ovarian cancer	4.65e-06	0.000146	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—CAV1—ovarian cancer	4.63e-06	0.000145	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.62e-06	0.000145	CbGpPWpGaD
Quinine—ABCB1—Metabolism—TYMS—ovarian cancer	4.59e-06	0.000144	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IL6ST—ovarian cancer	4.57e-06	0.000143	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CYP1B1—ovarian cancer	4.53e-06	0.000142	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CG—ovarian cancer	4.47e-06	0.00014	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CG—ovarian cancer	4.46e-06	0.00014	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.42e-06	0.000138	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CB—ovarian cancer	4.4e-06	0.000138	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—ABCB1—ovarian cancer	4.4e-06	0.000138	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CG—ovarian cancer	4.39e-06	0.000138	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—APC—ovarian cancer	4.39e-06	0.000138	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—NRAS—ovarian cancer	4.39e-06	0.000138	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—ABCB1—ovarian cancer	4.36e-06	0.000137	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—TYMS—ovarian cancer	4.32e-06	0.000135	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—TYMS—ovarian cancer	4.29e-06	0.000134	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—CAV1—ovarian cancer	4.24e-06	0.000133	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CG—ovarian cancer	4.22e-06	0.000132	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—MAPK3—ovarian cancer	4.21e-06	0.000132	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PTEN—ovarian cancer	4.09e-06	0.000128	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PTEN—ovarian cancer	4.08e-06	0.000128	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.05e-06	0.000127	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	4.02e-06	0.000126	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—MAPK1—ovarian cancer	4e-06	0.000125	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—EGFR—ovarian cancer	4e-06	0.000125	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4e-06	0.000125	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CD—ovarian cancer	3.93e-06	0.000123	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CD—ovarian cancer	3.92e-06	0.000123	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CG—ovarian cancer	3.86e-06	0.000121	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CD—ovarian cancer	3.86e-06	0.000121	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—FASN—ovarian cancer	3.84e-06	0.00012	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—PIK3CA—ovarian cancer	3.83e-06	0.00012	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PTEN—ovarian cancer	3.8e-06	0.000119	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—CAV1—ovarian cancer	3.79e-06	0.000119	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—KRAS—ovarian cancer	3.78e-06	0.000118	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.77e-06	0.000118	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—ABCB1—ovarian cancer	3.73e-06	0.000117	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CD—ovarian cancer	3.71e-06	0.000116	CbGpPWpGaD
Quinine—ABCB1—Metabolism—CAV1—ovarian cancer	3.7e-06	0.000116	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	3.67e-06	0.000115	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—TYMS—ovarian cancer	3.66e-06	0.000115	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.64e-06	0.000114	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.62e-06	0.000113	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.49e-06	0.000109	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CAV1—ovarian cancer	3.48e-06	0.000109	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—PIK3CA—ovarian cancer	3.47e-06	0.000109	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CAV1—ovarian cancer	3.45e-06	0.000108	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CG—ovarian cancer	3.45e-06	0.000108	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CB—ovarian cancer	3.43e-06	0.000107	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CB—ovarian cancer	3.42e-06	0.000107	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—ERBB2—ovarian cancer	3.41e-06	0.000107	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CD—ovarian cancer	3.4e-06	0.000106	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.37e-06	0.000105	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CB—ovarian cancer	3.37e-06	0.000105	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MTOR—ovarian cancer	3.37e-06	0.000105	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.3e-06	0.000103	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CXCL8—ovarian cancer	3.24e-06	0.000101	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CB—ovarian cancer	3.23e-06	0.000101	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—HRAS—ovarian cancer	3.21e-06	0.000101	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	3.17e-06	9.94e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CDKN1B—ovarian cancer	3.16e-06	9.9e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.15e-06	9.85e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—AKT1—ovarian cancer	3.13e-06	9.79e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.1e-06	9.71e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CASP3—ovarian cancer	3.1e-06	9.7e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IL2—ovarian cancer	3.09e-06	9.68e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—IL6—ovarian cancer	3.08e-06	9.64e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CD—ovarian cancer	3.03e-06	9.5e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CCND1—ovarian cancer	3.01e-06	9.44e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—AKT1—ovarian cancer	3e-06	9.4e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CTNNB1—ovarian cancer	2.98e-06	9.35e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CB—ovarian cancer	2.96e-06	9.28e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PTEN—ovarian cancer	2.96e-06	9.27e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CD—ovarian cancer	2.96e-06	9.27e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PTEN—ovarian cancer	2.95e-06	9.25e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CAV1—ovarian cancer	2.95e-06	9.24e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MMP9—ovarian cancer	2.93e-06	9.17e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PTEN—ovarian cancer	2.91e-06	9.11e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CA—ovarian cancer	2.88e-06	9.03e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CA—ovarian cancer	2.88e-06	9.02e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.88e-06	9.01e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—AKT1—ovarian cancer	2.84e-06	8.89e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—TYMS—ovarian cancer	2.83e-06	8.85e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.82e-06	8.83e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PTEN—ovarian cancer	2.79e-06	8.74e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.79e-06	8.74e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.76e-06	8.66e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.69e-06	8.42e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CA—ovarian cancer	2.68e-06	8.4e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.64e-06	8.28e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—VEGFA—ovarian cancer	2.63e-06	8.23e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—STAT3—ovarian cancer	2.6e-06	8.15e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—NRAS—ovarian cancer	2.6e-06	8.13e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.58e-06	8.08e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PTEN—ovarian cancer	2.56e-06	8.01e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MAPK3—ovarian cancer	2.49e-06	7.79e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.43e-06	7.61e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MYC—ovarian cancer	2.42e-06	7.57e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.41e-06	7.55e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MAPK1—ovarian cancer	2.37e-06	7.41e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—EGFR—ovarian cancer	2.36e-06	7.41e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.36e-06	7.4e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—AKT1—ovarian cancer	2.36e-06	7.38e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—AKT1—ovarian cancer	2.35e-06	7.37e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PTEN—ovarian cancer	2.28e-06	7.15e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CAV1—ovarian cancer	2.28e-06	7.13e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—KRAS—ovarian cancer	2.23e-06	7e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PTEN—ovarian cancer	2.23e-06	6.98e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—AKT1—ovarian cancer	2.19e-06	6.87e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PTEN—ovarian cancer	2.1e-06	6.58e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CA—ovarian cancer	2.09e-06	6.54e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CA—ovarian cancer	2.08e-06	6.53e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PTEN—ovarian cancer	2.08e-06	6.52e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.07e-06	6.5e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	2.06e-06	6.45e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CA—ovarian cancer	2.05e-06	6.43e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TP53—ovarian cancer	1.99e-06	6.22e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CA—ovarian cancer	1.97e-06	6.17e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—HRAS—ovarian cancer	1.9e-06	5.95e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.82e-06	5.71e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IL6—ovarian cancer	1.82e-06	5.69e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.81e-06	5.65e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PTEN—ovarian cancer	1.78e-06	5.57e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—AKT1—ovarian cancer	1.71e-06	5.34e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—AKT1—ovarian cancer	1.7e-06	5.33e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—AKT1—ovarian cancer	1.68e-06	5.25e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.61e-06	5.05e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—AKT1—ovarian cancer	1.61e-06	5.04e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.59e-06	4.98e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.57e-06	4.93e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.48e-06	4.64e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—AKT1—ovarian cancer	1.47e-06	4.62e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.47e-06	4.6e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PTEN—ovarian cancer	1.37e-06	4.3e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—AKT1—ovarian cancer	1.32e-06	4.12e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—AKT1—ovarian cancer	1.28e-06	4.02e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.26e-06	3.93e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—AKT1—ovarian cancer	1.21e-06	3.79e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—AKT1—ovarian cancer	1.2e-06	3.76e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—AKT1—ovarian cancer	1.03e-06	3.21e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	9.69e-07	3.03e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—AKT1—ovarian cancer	7.92e-07	2.48e-05	CbGpPWpGaD
